Mesenchymal stem cells and their secretome - candidates for safe and effective therapy for systemic lupus erythematosus

1 Kapsogeorgou EK., Tzioufas AG. Autoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation. Isr Med Assoc J. 2016;18:519–524. KapsogeorgouEK. TzioufasAG Autoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation Isr Med Assoc J 2016 18 519 524 Search in Google Scholar

2 Lerner A, Jeremias P, Matthias T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. Int J Celiac Dis. 2016;3(4); DOI:10.12691/ijcd-3-4-8. LernerA JeremiasP MatthiasT The World Incidence and Prevalence of Autoimmune Diseases is Increasing Int J Celiac Dis 2016 3 4 10.12691/ijcd-3-4-8 Open DOISearch in Google Scholar

3 Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3–4); DOI:10.1016/j.jaut.2009.09.008. CooperGS BynumMLK SomersEC Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases J Autoimmun 2009 33 3–4 10.1016/j.jaut.2009.09.008 278342219819109 Open DOISearch in Google Scholar

4 Singh RR, Yen EY. SLE mortality remains disproportionately high, despite improvements over the last decade. Lupus. 2018;27(10); DOI:10.1177/0961203318786436. SinghRR YenEY SLE mortality remains disproportionately high, despite improvements over the last decade Lupus 2018 27 10 10.1177/0961203318786436 608272730016928 Open DOISearch in Google Scholar

5 Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2); DOI:10.1097/BOR.0000000000000480. StojanG PetriM Epidemiology of systemic lupus erythematosus: an update Curr Opin Rheumatol 2018 30 2 10.1097/BOR.0000000000000480 602654329251660 Open DOISearch in Google Scholar

6 Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56(11); DOI:10.1093/rheumatology/kex260. ReesF DohertyM GraingeMJ LanyonP ZhangW The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies Rheumatology 2017 56 11 10.1093/rheumatology/kex260 28968809 Open DOISearch in Google Scholar

7 Montero-López E, Santos-Ruiz A, Navarrete-Navarrete N, Ortego-Centeno N, Pérez-García M, Peralta-Ramírez MI. The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus. Lupus. 2016;25(13); DOI:10.1177/0961203316642313. Montero-LópezE Santos-RuizA Navarrete-NavarreteN Ortego-CentenoN Pérez-GarcíaM Peralta-RamírezMI The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus Lupus 2016 25 13 10.1177/0961203316642313 27055522 Open DOISearch in Google Scholar

8 Christopeit M, Schendel M, Föll J, Müller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia. 2008;22(5); DOI:10.1038/sj.leu.2404996. ChristopeitM SchendelM FöllJ MüllerLP KeysserG BehreG Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L Leukemia 2008 22 5 10.1038/sj.leu.2404996 17972956 Open DOISearch in Google Scholar

9 Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice. Biol Blood Marrow Transplant. 2008;14(6); DOI:10.1016/j.bbmt.2008.01.006. EzquerFE EzquerME ParrauDB CarpioD YañezAJ CongetPA Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice Biol Blood Marrow Transplant 2008 14 6 10.1016/j.bbmt.2008.01.006 18489988 Open DOISearch in Google Scholar

10 Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, Noël D. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5); DOI:10.7150/thno.21072. CosenzaS ToupetK MaumusM Luz-CrawfordP Blanc-BrudeO JorgensenC NoëlD Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis Theranostics 2018 8 5 10.7150/thno.21072 583594529507629 Open DOISearch in Google Scholar

11 Eleuteri S, Fierabracci A. Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. Int J Mol Sci. 2019;20(18); DOI:10.3390/ijms20184597. EleuteriS FierabracciA Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications Int J Mol Sci 2019 20 18 10.3390/ijms20184597 677023931533317 Open DOISearch in Google Scholar

12 Sharma J, Hampton JM, Valiente GR, Wada T, Steigelman H, Young MC, Spurbeck RR, Blazek AD, Bösh S, Jarjour WN, Young NA. Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus. Front Immunol. 2017;8; DOI:10.3389/fimmu.2017.00526. SharmaJ HamptonJM ValienteGR WadaT SteigelmanH YoungMC SpurbeckRR BlazekAD BöshS JarjourWN YoungNA Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus Front Immunol 2017 8 10.3389/fimmu.2017.00526 Open DOISearch in Google Scholar

13 GfK Roper. Lupus Awareness Survey for the Lupus Foundation of America. GfK Roper Public Aff Corp Commun. 2012. GfK Roper Lupus Awareness Survey for the Lupus Foundation of America GfK Roper Public Aff Corp Commun 2012 Search in Google Scholar

14 MichetI CJ, McKenna CH, Elveback LR, Kaslov RA, Kurland LT. Epidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 Through 1979. Mayo Clin Proc. 1985;60(2); DOI:10.1016/S0025-6196(12)60294-8. MichetICJ McKennaCH ElvebackLR KaslovRA KurlandLT Epidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 Through 1979 Mayo Clin Proc 1985 60 2 10.1016/S0025-6196(12)60294-8 Open DOISearch in Google Scholar

15 Flower C, Hennis AJM, Hambleton IR, Nicholson GD, Liang MH. Systemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados national lupus registry. Arthritis Care Res (Hoboken). 2012; DOI:10.1002/acr.21656. FlowerC HennisAJM HambletonIR NicholsonGD LiangMH Systemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados national lupus registry Arthritis Care Res (Hoboken) 2012 10.1002/acr.21656 Open DOISearch in Google Scholar

16 Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, Rampudda M, Canova M, Doria A. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201. ZenM GhirardelloA IaccarinoL TononM CampanaC ArientiS RampuddaM CanovaM DoriaA Hormones, immune response, and pregnancy in healthy women and SLE patients Swiss Med Wkly 2010 140 187 201 Search in Google Scholar

17 Azevedo PC, Murphy G, Isenberg DA. Pathology of Systemic Lupus Erythematosus: The Challenges Ahead. In: ; 2014. DOI:10.1007/978-1-4939-0326-9_1. AzevedoPC MurphyG IsenbergDA Pathology of Systemic Lupus Erythematosus: The Challenges Ahead In: ; 2014 10.1007/978-1-4939-0326-9_1 Open DOISearch in Google Scholar

18 Ruperto N, Hanrahan L, Alarcón G, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5); DOI:10.1177/0961203310388445. RupertoN HanrahanL AlarcónG International consensus for a definition of disease flare in lupus Lupus 2011 20 5 10.1177/0961203310388445 Open DOISearch in Google Scholar

19 Fernandez D, Kirou KA. What Causes Lupus Flares? Curr Rheumatol Rep. 2016;18(3); DOI:10.1007/s11926-016-0562-3. FernandezD KirouKA What Causes Lupus Flares? Curr Rheumatol Rep 2016 18 3 10.1007/s11926-016-0562-3 Open DOISearch in Google Scholar

20 Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2017;29(5); DOI:10.1097/BOR.0000000000000411. ChenL MorrisDL VyseTJ Genetic advances in systemic lupus erythematosus: an update Curr Opin Rheumatol 2017 29 5 10.1097/BOR.0000000000000411 Open DOISearch in Google Scholar

21 Sullivan KE. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am. 2000;26(2); DOI:10.1016/S0889-857X(05)70137-X. SullivanKE Genetics of systemic lupus erythematosus Rheum Dis Clin North Am 2000 26 2 10.1016/S0889-857X(05)70137-X Open DOISearch in Google Scholar

22 James JA, Robertson JM. Lupus and Epstein-Barr. Curr Opin Rheumatol. 2012;24(4); DOI:10.1097/BOR.0b013e3283535801. JamesJA RobertsonJM Lupus and Epstein-Barr Curr Opin Rheumatol 2012 24 4 10.1097/BOR.0b013e3283535801 356234822504579 Open DOISearch in Google Scholar

23 Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, Kalden JR, Herrmann M. SLE—a disease of clearance deficiency? Rheumatology. 2005;44(9); DOI:10.1093/rheumatology/keh693. MunozLE GaiplUS FranzS SheriffA VollRE KaldenJR HerrmannM SLE—a disease of clearance deficiency? Rheumatology 2005 44 9 10.1093/rheumatology/keh693 15928001 Open DOISearch in Google Scholar

24 Jung J-Y, Suh C-H. Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker. Int J Rheum Dis. 2015;18(3); DOI:10.1111/1756-185X.12568. JungJ-Y SuhC-H Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker Int J Rheum Dis 2015 18 3 10.1111/1756-185X.12568 25884792 Open DOISearch in Google Scholar

25 Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst A-M, Davis LS. Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology. 2017;56(suppl_1); DOI:10.1093/rheumatology/kew427. ZharkovaO CelharT CravensPD SatterthwaiteAB FairhurstA-M DavisLS Pathways leading to an immunological disease: systemic lupus erythematosus Rheumatology 2017 56 suppl_1 10.1093/rheumatology/kew427 541097828375453 Open DOISearch in Google Scholar

26 Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2017;13(5); DOI:10.1038/nrrheum.2017.43. MorelL Immunometabolism in systemic lupus erythematosus Nat Rev Rheumatol 2017 13 5 10.1038/nrrheum.2017.43 28360423 Open DOISearch in Google Scholar

27 Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262(5); DOI:10.1111/j.1365-2796.2007.01844.x. Le BlancK RingdénO Immunomodulation by mesenchymal stem cells and clinical experience J Intern Med 2007 262 5 10.1111/j.1365-2796.2007.01844.x 17949362 Open DOISearch in Google Scholar

28 Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis. 1996;55(3); DOI:10.1136/ard.55.3.149. TyndallA GratwohlA Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases Ann Rheum Dis 1996 55 3 10.1136/ard.55.3.149 10101168712875 Open DOISearch in Google Scholar

29 Zhu Y, Feng X. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus. Stem Cell Res Ther. 2018;9(1); DOI:10.1186/s13287-018-0898-x. ZhuY FengX Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus Stem Cell Res Ther 2018 9 1 10.1186/s13287-018-0898-x 596846229793537 Open DOISearch in Google Scholar

30 Sun L, Zhang H, Feng X, Hou Y, Lu L, Fan L. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16(2); DOI:10.1177/0961203306075793. SunL ZhangH FengX HouY LuL FanL Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus Lupus 2007 16 2 10.1177/0961203306075793 17402368 Open DOISearch in Google Scholar

31 Fathollahi A, Gabalou NB, Aslani S. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder. Lupus. 2018;27(7); DOI:10.1177/0961203318768889. FathollahiA GabalouNB AslaniS Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder Lupus 2018 27 7 10.1177/0961203318768889 29631514 Open DOISearch in Google Scholar

32 Wang D, Sun L. Systemic Lupus Erythematosus. In: Chen X. D., ed. A Roadmap to Non-Hematopoietic Stem Cell-Based Therapeutics. Academic Press.; 2019:143–172. WangD SunL Systemic Lupus Erythematosus In: ChenX. D. ed. A Roadmap to Non-Hematopoietic Stem Cell-Based Therapeutics Academic Press 2019 143 172 10.1016/B978-0-12-811920-4.00007-0 Search in Google Scholar

33 Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, Lu L, Zeng X, Sun L. Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus. Clin Dev Immunol. 2012;2012; DOI:10.1155/2012/826182. TangY MaX ZhangH GuZ HouY GilkesonGS LuL ZengX SunL Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus Clin Dev Immunol 2012 2012 10.1155/2012/826182 343314222966240 Open DOISearch in Google Scholar

34 Xu J. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus. In: ; 2018. DOI:10.1007/5584_2018_212. XuJ Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus In: ; 2018 10.1007/5584_2018_212 29767288 Open DOISearch in Google Scholar

35 Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Mönckeberg G, Figueroa F. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19(3); DOI:10.1177/0961203309348983. CarrionF NovaE RuizC DiazF InostrozaC RojoD MönckebergG FigueroaF Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients Lupus 2010 19 3 10.1177/0961203309348983 19919974 Open DOISearch in Google Scholar

36 Barbado J, Tabera S, Sánchez A, García-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018;27(13); DOI:10.1177/0961203318804922. BarbadoJ TaberaS SánchezA García-SanchoJ Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis Lupus 2018 27 13 10.1177/0961203318804922 30290717 Open DOISearch in Google Scholar

37 Wallace DJ. The evolution of drug discovery in systemic lupus erythematosus. Nat Rev Rheumatol. 2015;11(10); DOI:10.1038/nrrheum.2015.86. WallaceDJ The evolution of drug discovery in systemic lupus erythematosus Nat Rev Rheumatol 2015 11 10 10.1038/nrrheum.2015.86 26122951 Open DOISearch in Google Scholar

38 Liang J, Sun L. Mesenchymal stem cells transplantation for systemic lupus erythematosus. Int J Rheum Dis. 2015;18(2); DOI:10.1111/1756-185X.12531. LiangJ SunL Mesenchymal stem cells transplantation for systemic lupus erythematosus Int J Rheum Dis 2015 18 2 10.1111/1756-185X.12531 25611801 Open DOISearch in Google Scholar

39 Fors Nieves CE, Izmirly PM. Mortality in Systemic Lupus Erythematosus: an Updated Review. Curr Rheumatol Rep. 2016;18(4); DOI:10.1007/s11926-016-0571-2. Fors NievesCE IzmirlyPM Mortality in Systemic Lupus Erythematosus: an Updated Review Curr Rheumatol Rep 2016 18 4 10.1007/s11926-016-0571-2 26984805 Open DOISearch in Google Scholar

40 Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek D V., Schoeberlein A. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid. Best Pract Res Clin Obstet Gynaecol. 2016;31; DOI:10.1016/j.bpobgyn.2015.07.006. Joerger-MesserliMS MarxC OppligerB MuellerM SurbekD V. SchoeberleinA Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid Best Pract Res Clin Obstet Gynaecol 2016 31 10.1016/j.bpobgyn.2015.07.006 26482184 Open DOISearch in Google Scholar

41 Araújo AB, Salton GD, Furlan JM, Schneider N, Angeli MH, Laureano A M, Silla L, Passos EP, Paz AH. Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy. 2017;19(5); DOI:10.1016/j.jcyt.2017.03.001. AraújoAB SaltonGD FurlanJM SchneiderN AngeliMH LaureanoAM SillaL PassosEP PazAH Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord Cytotherapy 2017 19 5 10.1016/j.jcyt.2017.03.001 28343898 Open DOISearch in Google Scholar

42 Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F., Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4); DOI:10.1080/14653240600855905. DominiciM Le BlancK MuellerI Slaper-CortenbachI MariniF. KrauseDS DeansRJ KeatingA ProckopDJ HorwitzEM Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 2006 8 4 10.1080/14653240600855905 16923606 Open DOISearch in Google Scholar

43 Friedenstein AJ., Gorskaja JF., Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–274; FriedensteinAJ. GorskajaJF. KulaginaNN Fibroblast precursors in normal and irradiated mouse hematopoietic organs Exp Hematol 1976 4 267 274 Search in Google Scholar

44 Calloni R, Cordero EAA, Henriques JAP, Bonatto D. Reviewing and Updating the Major Molecular Markers for Stem Cells. Stem Cells Dev. 2013;22(9); DOI:10.1089/scd.2012.0637. CalloniR CorderoEAA HenriquesJAP BonattoD Reviewing and Updating the Major Molecular Markers for Stem Cells Stem Cells Dev 2013 22 9 10.1089/scd.2012.0637 362977823336433 Open DOISearch in Google Scholar

45 Choi EW, Lee HW, Shin IS, Park JH, Yun TW, Youn HY, Kim S-J. Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus. Cell Transplant. 2016;25(6); DOI:10.3727/096368915X689442. ChoiEW LeeHW ShinIS ParkJH YunTW YounHY KimS-J Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus Cell Transplant 2016 25 6 10.3727/096368915X689442 26377835 Open DOISearch in Google Scholar

46 Shin H, Ryu HH, Kwon O, Park B-S, Jo SJ. Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study. Int J Dermatol. 2015;54(6); DOI:10.1111/ijd.12650. ShinH RyuHH KwonO ParkB-S JoSJ Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study Int J Dermatol 2015 54 6 10.1111/ijd.12650 25777970 Open DOISearch in Google Scholar

47 Mita T, Furukawa-Hibi Y, Takeuchi H, Hattori H, Yamada K, Hibi H, Ueda M, Yamamoto A. Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease. Behav Brain Res. 2015;293; DOI:10.1016/j.bbr.2015.07.043. MitaT Furukawa-HibiY TakeuchiH HattoriH YamadaK HibiH UedaM YamamotoA Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease Behav Brain Res 2015 293 10.1016/j.bbr.2015.07.043 26210934 Open DOISearch in Google Scholar

48 Tracy SA, Ahmed A, Tigges JC, Ericsson M, Pal AK, Zurakowski D, Fauza DO. A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid. J Pediatr Surg. 2019;54(1); DOI:10.1016/j.jpedsurg.2018.10.020. TracySA AhmedA TiggesJC EricssonM PalAK ZurakowskiD FauzaDO A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid J Pediatr Surg 2019 54 1 10.1016/j.jpedsurg.2018.10.020 30361074 Open DOISearch in Google Scholar

49 Harris L, Vangsness CT. Mesenchymal Stem Cell Levels of Human Spinal Tissues. Spine (Phila Pa 1976). 2018;43(9); DOI:10.1097/BRS.0000000000002401. HarrisL VangsnessCT Mesenchymal Stem Cell Levels of Human Spinal Tissues Spine (Phila Pa 1976) 2018 43 9 10.1097/BRS.0000000000002401 28885289 Open DOISearch in Google Scholar

50 Davies JE, Walker JT, Keating A. Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells. Stem Cells Transl Med. 2017;6(7); DOI:10.1002/sctm.16-0492. DaviesJE WalkerJT KeatingA Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells Stem Cells Transl Med 2017 6 7 10.1002/sctm.16-0492 568977228488282 Open DOISearch in Google Scholar

51 Ding D-C, Chang Y-H, Shyu W-C, Lin S-Z. Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy. Cell Transplant. 2015;24(3); DOI:10.3727/096368915X686841. DingD-C ChangY-H ShyuW-C LinS-Z Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy Cell Transplant 2015 24 3 10.3727/096368915X686841 25622293 Open DOISearch in Google Scholar

52 La Rocca G. Novel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative Medicine. Open Tissue Eng Regen Med J. 2012;5(1); DOI:10.2174/1875043501205010050. La RoccaG Novel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative Medicine Open Tissue Eng Regen Med J 2012 5 1 10.2174/1875043501205010050 Open DOISearch in Google Scholar

53 Tong CK, Vellasamy S, Chong Tan B, Abdullah M, Vidyadaran S, Fong Seow H, Ramasamy R. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int. 2011;35(3); DOI:10.1042/CBI20100326. TongCK VellasamyS Chong TanB AbdullahM VidyadaranS Fong SeowH RamasamyR Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method Cell Biol Int 2011 35 3 10.1042/CBI20100326 20946106 Open DOISearch in Google Scholar

54 Rubtsov Y, Goryunov K, Romanov A, Suzdaltseva Y, Sharonov G, Tkachuk V. Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1. Stem Cells Int. 2017;2017; DOI:10.1155/2017/6516854. RubtsovY GoryunovK RomanovA SuzdaltsevaY SharonovG TkachukV Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1 Stem Cells Int 2017 2017 10.1155/2017/6516854 551849728761447 Open DOISearch in Google Scholar

55 Pistoia V, Raffaghello L. Mesenchymal stromal cells and autoimmunity. Int Immunol. 2017;29(2); DOI:10.1093/intimm/dxx008. PistoiaV RaffaghelloL Mesenchymal stromal cells and autoimmunity Int Immunol 2017 29 2 10.1093/intimm/dxx008 28338763 Open DOISearch in Google Scholar

56 Che N, Li X, Zhou S, Liu R, Shi D, Lu L, Sun L. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol. 2012;274(1–2); DOI:10.1016/j.cellimm.2012.02.004. CheN LiX ZhouS LiuR ShiD LuL SunL Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation Cell Immunol 2012 274 1–2 10.1016/j.cellimm.2012.02.004 22414555 Open DOISearch in Google Scholar

57 Asari S, Itakura S, Ferreri K, Liu C-P, Kuroda Y, Kandeel F, Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol. 2009;37(5); DOI:10.1016/j.exphem.2009.01.005. AsariS ItakuraS FerreriK LiuC-P KurodaY KandeelF MullenY Mesenchymal stem cells suppress B-cell terminal differentiation Exp Hematol 2009 37 5 10.1016/j.exphem.2009.01.005 274766119375651 Open DOISearch in Google Scholar

58 Ribeiro A, Laranjeira P, Mendes S, Velada I, Leite C, Andrade P, Santos F, Henriques A, Grãos M, Cardoso CMP, Martinho A, Pais Ml, da Silva C, Cabral J, Trindade H, Paiva A. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther. 2013;4(5); DOI:10.1186/scrt336. RibeiroA LaranjeiraP MendesS VeladaI LeiteC AndradeP SantosF HenriquesA GrãosM CardosoCMP MartinhoA PaisMl da SilvaC CabralJ TrindadeH PaivaA Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells Stem Cell Res Ther 2013 4 5 10.1186/scrt336 385470224406104 Open DOISearch in Google Scholar

59 Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin M-N, Forner K, Basik M, Galipeau J. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner. J Immunol. 2009;182(10); DOI:10.4049/jimmunol.0803962. RafeiM CampeauPM Aguilar-MahechaA BuchananM WilliamsP BirmanE YuanS YoungYK BoivinM-N FornerK BasikM GalipeauJ Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner J Immunol 2009 182 10 10.4049/jimmunol.0803962 19414750 Open DOISearch in Google Scholar

60 Cheng R-J, Xiong A-J, Li Y-H, Pan S-Y, Zhang Q-P, Zhao Y, Liu Y, Marion TN. Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients. Front Cell Dev Biol. 2019;7; DOI:10.3389/fcell.2019.00285. ChengR-J XiongA-J LiY-H PanS-Y ZhangQ-P ZhaoY LiuY MarionTN Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients Front Cell Dev Biol 2019 7 10.3389/fcell.2019.00285 687414431799252 Open DOISearch in Google Scholar

61 Perez-Hernandez J, Redon J, Cortes R. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus. Int J Mol Sci. 2017;18(4); DOI:10.3390/ijms18040717. Perez-HernandezJ RedonJ CortesR Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus Int J Mol Sci 2017 18 4 10.3390/ijms18040717 541230328350323 Open DOISearch in Google Scholar

62 Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6); DOI:10.1038/aps.2017.12. LuanX SansanaphongprichaK MyersI ChenH YuanH SunD Engineering exosomes as refined biological nanoplatforms for drug delivery Acta Pharmacol Sin 2017 38 6 10.1038/aps.2017.12 552018428392567 Open DOISearch in Google Scholar

63 Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4); DOI:10.1083/jcb.201211138. RaposoG StoorvogelW Extracellular vesicles: Exosomes, microvesicles, and friends J Cell Biol 2013 200 4 10.1083/jcb.201211138 357552923420871 Open DOISearch in Google Scholar

64 Mathivanan S, Simpson RJ. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics. 2009;9(21); DOI:10.1002/pmic.200900351. MathivananS SimpsonRJ ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009 9 21 10.1002/pmic.200900351 19810033 Open DOISearch in Google Scholar

65 Qiu G, Zheng G, Ge M, Wang J, Huang R, Shu Q, Xu J. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018;9(1); DOI:10.1186/s13287-018-1069-9. QiuG ZhengG GeM WangJ HuangR ShuQ XuJ Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs Stem Cell Res Ther 2018 9 1 10.1186/s13287-018-1069-9 624982630463593 Open DOISearch in Google Scholar

66 Celhar T, Fairhurst A-M. Modelling clinical systemic lupus erythematosus: similarities, differences and success stories. Rheumatology. December 2016; DOI:10.1093/rheumatology/kew400. CelharT FairhurstA-M Modelling clinical systemic lupus erythematosus: similarities, differences and success stories Rheumatology December 2016 10.1093/rheumatology/kew400 541099028013204 Open DOISearch in Google Scholar

67 Li W, Titov AA, Morel L. An update on lupus animal models. Curr Opin Rheumatol. 2017;29(5); DOI:10.1097/BOR.0000000000000412. LiW TitovAA MorelL An update on lupus animal models Curr Opin Rheumatol 2017 29 5 10.1097/BOR.0000000000000412 581539128537986 Open DOISearch in Google Scholar

68 Xu Y, Zeumer L, Reeves WH, Morel L. Induced Murine Models of Systemic Lupus Erythematosus. In: ; 2014. DOI:10.1007/978-1-4939-0326-9_9. XuY ZeumerL ReevesWH MorelL Induced Murine Models of Systemic Lupus Erythematosus In: ; 2014 10.1007/978-1-4939-0326-9_9 24497358 Open DOISearch in Google Scholar

69 Wang D, Niu L, Feng X, Yuan X, Zhao S, Zhang H, Liang J, Zhao C, Wang H, Hua B, Sun L. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med. 2017;17(3); DOI:10.1007/s10238-016-0427-0. WangD NiuL FengX YuanX ZhaoS ZhangH LiangJ ZhaoC WangH HuaB SunL Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study Clin Exp Med 2017 17 3 10.1007/s10238-016-0427-0 27270729 Open DOISearch in Google Scholar

70 Zhang Y, Xia Y, Ni S, Gu Z, Liu H. Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice. J Thorac Dis. 2014;6:109–117; ZhangY XiaY NiS GuZ LiuH Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice J Thorac Dis 2014 6 109 117 Search in Google Scholar

71 Li X, Wang D, Liang J, Zhang H, Sun L. Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transplant. 2013;48(4); DOI:10.1038/bmt.2012.184. LiX WangD LiangJ ZhangH SunL Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus Bone Marrow Transplant 2013 48 4 10.1038/bmt.2012.184 23064040 Open DOISearch in Google Scholar

72 Jang E, Jeong M, Kim S, Jang K, Kang B-K, Lee DY, Bae S-C, Kim KS, Youn J. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development. Cell Transplant. 2016;25(1); DOI:10.3727/096368915X688173. JangE JeongM KimS JangK KangB-K LeeDY BaeS-C KimKS YounJ Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development Cell Transplant 2016 25 1 10.3727/096368915X688173 25975931 Open DOISearch in Google Scholar

73 Thiel A, Yavanian G, Nastke M-D, Morales P, Kouris NA, Kimbrel EA, Lanza R. Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis. Sci Rep. 2016;5(1); DOI:10.1038/srep17685. ThielA YavanianG NastkeM-D MoralesP KourisNA KimbrelEA LanzaR Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis Sci Rep 2016 5 1 10.1038/srep17685 466721326628350 Open DOISearch in Google Scholar

74 Mai S, Zou L, Tian X, Liao X, Luan Y, Han X, Wei Y, Wu Y, Kuang S, Yang Y, Ma J, Chen Q, Yang J. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Mol Pharm. 2018;15(5); DOI:10.1021/acs.molpharmaceut.7b01146. MaiS ZouL TianX LiaoX LuanY HanX WeiY WuY KuangS YangY MaJ ChenQ YangJ Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice Mol Pharm 2018 15 5 10.1021/acs.molpharmaceut.7b01146 29668284 Open DOISearch in Google Scholar

75 Chang J-W, Hung S-P, Wu H-H, Wu W-M, Yang A-H, Tsai H-L, Yang L-Y, Lee OK. Therapeutic Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation in Experimental Lupus Nephritis. Cell Transplant. 2011;20(2); DOI:10.3727/096368910X520056. ChangJ-W HungS-P WuH-H WuW-M YangA-H TsaiH-L YangL-Y LeeOK Therapeutic Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation in Experimental Lupus Nephritis Cell Transplant 2011 20 2 10.3727/096368910X520056 20719085 Open DOISearch in Google Scholar

76 Zhang Z, Feng R, Niu L, Huang S, Deng W, Shi B, Yao G, Chen W, Tang X, Gao X, Feng X, Sun L. Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL- Fas ^lpr Mice. Cell Transplant. 2017;26(6); DOI:10.3727/096368917X694660. ZhangZ FengR NiuL HuangS DengW ShiB YaoG ChenW TangX GaoX FengX SunL Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL- Fas ^lpr Mice Cell Transplant 2017 26 6 10.3727/096368917X694660 565774628105982 Open DOISearch in Google Scholar

77 Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin Immunol. 2012;145(2); DOI:10.1016/j.clim.2012.08.012. GuF MolanoI RuizP SunL GilkesonGS Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice Clin Immunol 2012 145 2 10.1016/j.clim.2012.08.012 23041504 Open DOISearch in Google Scholar

78 Che N, Li X, Zhang L, Liu R, Chen H, Gao X, Shi S, Chen W, Sun L. Impaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression. J Immunol. 2014;193(10); DOI:10.4049/jimmunol.1400036. CheN LiX ZhangL LiuR ChenH GaoX ShiS ChenW SunL Impaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression J Immunol 2014 193 10 10.4049/jimmunol.1400036 25339674 Open DOISearch in Google Scholar

79 Li T, Xia M, Gao Y, Chen Y, Xu Y. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther. 2015;15(9); DOI:10.1517/14712598.2015.1051528. LiT XiaM GaoY ChenY XuY Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy Expert Opin Biol Ther 2015 15 9 10.1517/14712598.2015.1051528 26067213 Open DOISearch in Google Scholar

80 Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol. 2011;272(1); DOI:10.1016/j.cellimm.2011.09.010. ZhouC YangB TianY JiaoH ZhengW WangJ GuanF Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes Cell Immunol 2011 272 1 10.1016/j.cellimm.2011.09.010 323532622004796 Open DOISearch in Google Scholar

81 Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5); DOI:10.1038/cmi.2015.89. WangD HuangS YuanX LiangJ XuR YaoG FengX SunL The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus Cell Mol Immunol 2017 14 5 10.1038/cmi.2015.89 542308426435067 Open DOISearch in Google Scholar

82 Driscoll J, Patel T. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease. J Gastroenterol. 2019;54(9); DOI:10.1007/s00535-019-01599-1. DriscollJ PatelT The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease J Gastroenterol 2019 54 9 10.1007/s00535-019-01599-1 669826131270691 Open DOISearch in Google Scholar

83 Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1); DOI:10.1080/20013078.2018.1535750. ThéryC WitwerKW AikawaE Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines J Extracell Vesicles 2018 7 1 10.1080/20013078.2018.1535750 632235230637094 Open DOISearch in Google Scholar

84 Chudickova M, Vackova I, Machova Urdzikova L, Jancova P, Kekulova K, Rehorova M, Turnovcova K, Jendelova P, Kubinova S. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury. Int J Mol Sci. 2019;20(18); DOI:10.3390/ijms20184516. ChudickovaM VackovaI Machova UrdzikovaL JancovaP KekulovaK RehorovaM TurnovcovaK JendelovaP KubinovaS The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury Int J Mol Sci 2019 20 18 10.3390/ijms20184516 677054531547264 Open DOISearch in Google Scholar

85 Giacoppo S, Thangavelu SR, Diomede F, Bramanti P, Conti P, Trubiani O, Mazzon E. Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. FASEB J. 2017;31(12); DOI:10.1096/fj.201700524R. GiacoppoS ThangaveluSR DiomedeF BramantiP ContiP TrubianiO MazzonE Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 FASEB J 2017 31 12 10.1096/fj.201700524R 569038228842429 Open DOISearch in Google Scholar

86 Pouya S, Heidari M, Baghaei K, Asadzadeh Aghdaei H, Moradi A, Namaki S, Zali MR, Hashemi SM. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018;54; DOI:10.1016/j.intimp.2017.11.001. PouyaS HeidariM BaghaeiK Asadzadeh AghdaeiH MoradiA NamakiS ZaliMR HashemiSM Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis Int Immunopharmacol 2018 54 10.1016/j.intimp.2017.11.001 29112894 Open DOISearch in Google Scholar

87 Katagiri W, Osugi M, Kawai T, Hibi H. First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells. Head Face Med. 2016;12(1); DOI:10.1186/s13005-016-0101-5. KatagiriW OsugiM KawaiT HibiH First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells Head Face Med 2016 12 1 10.1186/s13005-016-0101-5 471445926772731 Open DOISearch in Google Scholar

88 Fukuoka H, Suga H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. . Eplasty. 2015;15:e10. FukuokaH SugaH Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms Eplasty 2015 15 e10 Search in Google Scholar

89 Lauxmann MA, Santucci NE, Autrán-Gómez AM. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. Int braz j urol. 2020;46(suppl 1); DOI:10.1590/s1677-5538.ibju.2020.s101. LauxmannMA SantucciNE Autrán-GómezAM The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak Int braz j urol 2020 46 suppl 1 10.1590/s1677-5538.ibju.2020.s101 Open DOISearch in Google Scholar